SciSparc (SPRC)

• Market cap: $3.94M
• 1 day: -0.87%
• 5 days: -2.69%
• 1 month: 46.17%
• 3 months: 13.37%
• 6 months: 15.46%
• Year to date: -45.48%
• 1 year: -85.71%
• 5 years: -99.98%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Employees: 3